biologic drug - Robuta Search

https://webinars.endpoints.news/breakthrough-technologies-to-accelerate-biologic-drug-discovery-cell-line-development-and-biomanufacturability/ Breakthrough technologies to accelerate Biologic Drug Discovery, Cell Line Development and... A chronic challenge facing biologic drug discovery companies is the manufacturability of lead candidates. How do you ensure that the most promising hits from... cell line development breakthrough technologies biologic drug accelerate discovery https://www.protagene.com/ ProtaGene | Analytical Excellence | Biologic Drug & Cell & Gene Therapy Mar 11, 2026 - ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we... cell gene therapy biologic drug analytical excellence https://pharmaoffer.com/contract-services/cmo/biologic-products Biologic Drug CDMOs | Protein & Vaccine Manufacturing Find CDMOs for biologic drug products. End-to-end services for therapeutic proteins, monoclonal antibodies, and vaccines. biologic drug vaccine manufacturing cdmos protein https://www.fdli.org/2021/04/biologic-biosimilar-litigation-ip-rights/ Biologic and Biosimilar Litigation and IP Rights - Food and Drug Law Institute (FDLI) Jul 19, 2024 - Recorded April 27, 2021 | On-Demand Webinar food drug law litigation ip institute fdli biologic biosimilar https://www.medpace.com/ Drug and Biologic Contract Research Organization (CRO) | Medpace Apr 24, 2026 - Medpace offers clinical pharmacology and laboratory services including central laboratory, bioanalytical, ECG core lab, and imaging core labs. Learn more. research organization cro drug biologic contract medpace https://www.fda.gov/drugs/how-drugs-are-developed-and-approved/drug-and-biologic-approval-and-ind-activity-reports Drug and Biologic Approval and IND Activity Reports | FDA Drug and Biologic Approval and IND Activity Reports activity reports drug biologic approval ind https://policy.tennessee.edu/procedure/dbd002-drug-biologic-device-significant-risk-nonsignificant-risk-determinations-for-medical-device-studies/ DBD002 - Drug, Biologic Device - Significant Risk/Nonsignificant Risk Determinations for Medical... Jul 25, 2025 - UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD SIGNIFICANT RISK / NONSIGNIFICANT RISK DETERMINATIONS FOR MEDICAL DEVICE STUDIES drug biologic device significant risk https://www.fda.gov/drugs/development-resources/surrogate-endpoint-resources-drug-and-biologic-development Surrogate Endpoint Resources for Drug and Biologic Development | FDA A clinical trial’s endpoints measure the outcomes in the trial. When a trial evaluates the efficacy of a new medical product or a new use for an approved... development fda surrogate endpoint resources drug